These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 2245691)

  • 41. The comparison of myocardial dysfunction in three forms of experimental septic shock.
    Peevy KJ; Reed T; Chartrand SA; Olson RD; Boerth RC
    Pediatr Res; 1986 Dec; 20(12):1240-2. PubMed ID: 3540827
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibiotics versus cardiovascular support in a canine model of human septic shock.
    Natanson C; Danner RL; Reilly JM; Doerfler ML; Hoffman WD; Akin GL; Hosseini JM; Banks SM; Elin RJ; MacVittie TJ
    Am J Physiol; 1990 Nov; 259(5 Pt 2):H1440-7. PubMed ID: 2240243
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The pathophysiology of septic shock: changes in hemodynamics in rats following live E coli injection. An application of the thermodilution method for measurement of cardiac output.
    Sato T; Isoyama T; Tanaka J; Jones RT; Cowley RA; Trump BF
    Adv Shock Res; 1982; 7():25-42. PubMed ID: 6753536
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis.
    Buijs J; Dofferhoff AS; Mouton JW; van der Meer JW
    J Antimicrob Chemother; 2007 May; 59(5):926-33. PubMed ID: 17395686
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of a recombinant endotoxin-neutralizing protein on endotoxin shock in rabbits.
    Garcia C; Saladino R; Thompson C; Hammer B; Parsonnet J; Wainwright N; Novitsky T; Fleisher GR; Siber G
    Crit Care Med; 1994 Aug; 22(8):1211-8. PubMed ID: 8045139
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reversal of myocardial dysfunction in endotoxin shock with insulin.
    Archer LT; Beller BK; Drake JK; Whitsett TL; Hinshaw LB
    Can J Physiol Pharmacol; 1978 Feb; 56(1):132-8. PubMed ID: 346182
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A controlled trial of HA-1A in a canine model of gram-negative septic shock.
    Quezado ZM; Natanson C; Alling DW; Banks SM; Koev CA; Elin RJ; Hosseini JM; Bacher JD; Danner RL; Hoffman WD
    JAMA; 1993 May; 269(17):2221-7. PubMed ID: 8474201
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lack of defective cardiac oxidative metabolism in intact dogs subjected to a prolonged low-dose infusion of Escherichia coli endotoxin.
    D'Orio V; el Allaf D; Vaira S; Fossion A; Juchmes J; Marcelle R
    Circ Shock; 1986; 18(1):43-52. PubMed ID: 3080258
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Repeated plasma therapy induces fatal shock in experimental septicemia.
    Busund R; Lindsetmo RO; Balteskard L; Rekvig OP; Revhaug A
    Circ Shock; 1993 Aug; 40(4):268-75. PubMed ID: 8375029
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasma proteolysis and circulating cells in relation to varying endotoxin concentrations in porcine endotoxemia.
    Naess F; Roeise O; Pillgram-Larsen J; Ruud TE; Stadaas JO; Aasen AO
    Circ Shock; 1989 Jun; 28(2):89-100. PubMed ID: 2661049
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Splanchnic and systemic hemodynamic responses to portal vein endotoxin after resuscitation from hemorrhagic shock.
    Gavin TJ; Fabian TC; Wilson JD; Trenthem LL; Pritchard FE; Croce MA; Stewart RM; Proctor KG
    Surgery; 1994 Mar; 115(3):310-24. PubMed ID: 8128356
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of plasma administration on gram negative shock in granulocytopenic dogs.
    Crowley JP; Metzger J; Pivacek L; Dennis RC; Valeri CR
    Circ Shock; 1988 Nov; 26(3):287-95. PubMed ID: 3061684
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Escherichia coli endotoxin depresses left ventricular contractility in neonatal lambs.
    Sosa G; Milstein JM; Bennett SH
    Pediatr Res; 1994 Jan; 35(1):62-7. PubMed ID: 8134201
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of septic shock with a protease inhibitor in a canine model: a prospective, randomized, controlled trial.
    Tani T; Aoki H; Yoshioka T; Lin KJ; Kodama M
    Crit Care Med; 1993 Jun; 21(6):925-30. PubMed ID: 8389269
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of polyacrylonitrile (AN69) and polysulphone membrane during hemofiltration in canine endotoxic shock.
    Rogiers P; Zhang H; Pauwels D; Vincent JL
    Crit Care Med; 2003 Apr; 31(4):1219-25. PubMed ID: 12682496
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bioartificial kidney ameliorates gram-negative bacteria-induced septic shock in uremic animals.
    Fissell WH; Lou L; Abrishami S; Buffington DA; Humes HD
    J Am Soc Nephrol; 2003 Feb; 14(2):454-61. PubMed ID: 12538747
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gram negative septic shock. Experimental and clinical studies.
    Motsay GJ
    Int Surg; 1970 Aug; 54(2):81-92. PubMed ID: 4316996
    [No Abstract]   [Full Text] [Related]  

  • 58. A comparison of the cardiovascular, renal, and coronary effects of dopamine and monensin in endotoxic shock.
    Somani P; Saini RK
    Circ Shock; 1981; 8(4):451-64. PubMed ID: 7023738
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Escherichia coli sepsis and endotoxemia in conscious young pigs.
    Schrauwen E; Cox E; Houvenaghel A
    Vet Res Commun; 1988; 12(4-5):295-303. PubMed ID: 3057723
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Humoral factors in primate endotoxin shock.
    May M; Pohlson EC; Siri F; McNamara JJ
    Circ Shock; 1987; 22(2):127-39. PubMed ID: 3297377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.